Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Gut-X-001 in Alzheimer Disease: NCT07591727 Clinical Landscape Report 2026
18 September 2026
NCT07591727 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Indocyanine Green in Borderline epithelial tumor of ovary: NCT07593339 Clinical Landscape Report 2026
18 September 2026
NCT07593339 clinical landscape for Borderline epithelial tumor of ovary: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
LY3439539 in Alzheimer Disease: NCT07598370 Clinical Landscape Report 2026
18 September 2026
NCT07598370 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ALIA-1758 in Alzheimer Disease: NCT07599670 Clinical Landscape Report 2026
18 September 2026
NCT07599670 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Busulfan in Acute Myeloid Leukemia: NCT07588360 Clinical Landscape Report 2026
18 September 2026
NCT07588360 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lisaftoclax in Acute Promyelocytic Leukemia: NCT07597941 Clinical Landscape Report 2026
18 September 2026
NCT07597941 clinical landscape for Acute Promyelocytic Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lecanemab in Alzheimer Disease: NCT07604896 Clinical Landscape Report 2026
18 September 2026
NCT07604896 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pembrolizumab in Metastatic Carcinoma to the Uterine Cervix: CTRI/2026/05/110883 Clinical Landscape Report 2026
18 September 2026
CTRI/2026/05/110883 clinical landscape for Metastatic Carcinoma to the Uterine Cervix: endpoints, sponsor, phase, geography, readouts, asset context and deve…
9 min read
INT-210 in Inflammatory Bowel Diseases: NCT07616791 Clinical Landscape Report 2026
18 September 2026
NCT07616791 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Guselkumab in Crohn Disease: NCT07616687 Clinical Landscape Report 2026
18 September 2026
NCT07616687 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
IDP-001 in squamous cell carcinoma of the anus: NCT07602842 Clinical Landscape Report 2026
18 September 2026
NCT07602842 clinical landscape for squamous cell carcinoma of the anus: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
ZI-MA4-1 in Ovarian Cancer: NCT07613723 Clinical Landscape Report 2026
18 September 2026
NCT07613723 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.